212 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This study reveals that while the transport of larger particles to lymph nodes remains intact in aged mice, the accumulation of smaller 20nm antigens within B cell follicles is significantly impaired, potentially explaining the diminished vaccine responses observed in aging.
This study reveals that CD8+ T cells distinctively partition intracellular cysteine-derived sulfur into glutathione production to modulate effector functions and into FeS-cluster synthesis to support proliferation, demonstrating that manipulating this metabolic flux can prevent T cell exhaustion and enhance anti-tumor immunity.
This paper introduces the Residual Model, a robust and scalable approach implemented in the USERM R package, to accurately predict signal spread in spectral flow cytometry panel design by integrating statistical features from single-color controls under Ordinary Least Squares unmixing.
This study found that while cellular immune responses to SARS-CoV-2 and Epstein-Barr virus (EBV) did not differ between individuals with neuropsychiatric long COVID and recovered participants, diminished EBV-specific humoral immunity at 3–6 months post-onset was significantly associated with the development or persistence of fatigue and neuropsychiatric symptoms up to 12 months later.
This study demonstrates that pretreatment with β-glucan induces trained immunity in monocytes, reprogramming their differentiation toward a reparative phenotype that mitigates DSS-induced colitis and enhances bacterial clearance, thereby offering a promising therapeutic strategy for inflammatory bowel disease.
This study utilizes high-throughput screening to identify novel, highly immunogenic T-cell epitopes within the Human Cytomegalovirus IE2 protein, particularly a dominant CD4+ response region, which are proposed as promising candidates for future vaccine development.
This study identifies TAK1 as a critical signaling hub that links dsRNA recognition by RIG-I/MDA5-MAVS and/or TLR3-TRIF to NLRP1 inflammasome activation through TAK1-dependent phosphorylation of the NLRP1 N-terminal disordered region, operating independently of type I interferon.
This study identifies a critical early type I interferon-driven checkpoint within 24 hours of lethal viral infection that determines survival by priming a distinct, protective ICAM1+ neutrophil subset in the bone marrow, thereby establishing these cells as a key biomarker for protective immunity.
This study demonstrates that the dual CRISPR/Cas9-mediated inactivation of Regnase-1 and SOCS1 in CD8+ T cells synergistically rewires their differentiation from terminal exhaustion to an enhanced effector state with improved memory formation, thereby significantly boosting anti-tumor efficacy in both murine models and human T cell therapies.
This study reveals that the E3 ligase XIAP and deubiquitinase MYSM1 dynamically regulate NOD2-RIP2 signaling by opposing K27-linked inhibitory and K63-linked activating ubiquitination of RIP2, respectively, to fine-tune immune responses and prevent inflammatory disease.